Literature DB >> 15240005

The Rheb family of GTP-binding proteins.

Paul-Joseph Aspuria1, Fuyuhiko Tamanoi.   

Abstract

Rheb proteins represent a novel and unique family of the Ras superfamily GTP-binding proteins that is conserved from yeast to human. Biochemical studies establish that they bind and hydrolyze GTP. Molecular modeling studies reveal a few structural differences between Rheb and Ras, which may suggest that residues involved in biochemical activities differ between the two G-proteins. The function of Rheb has been studied in a number of organisms that point to the involvement of Rheb in cell growth and cell cycle progression. In addition, studies in fungi suggest that Rheb is involved in arginine uptake. Further studies in Drosophila and mammalian cells have shown that the effects of Rheb on growth and cell cycle progression are mediated by the effect on the insulin/TOR/S6K signaling pathway. These studies have also shown that a complex consisting of the tuberous sclerosis gene products, Tsc1/Tsc2, serves as a GTPase activating protein (GAP) for Rheb, implying Rheb's role in this genetic disorder. Finally, Rheb proteins have been shown to be farnesylated and small molecule inhibitors of protein farnesyltransferase can block the ability of Rheb to activate the TOR/S6K signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240005     DOI: 10.1016/j.cellsig.2004.03.019

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  79 in total

1.  ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

Authors:  Audrey Carriere; Yves Romeo; Hugo A Acosta-Jaquez; Julie Moreau; Eric Bonneil; Pierre Thibault; Diane C Fingar; Philippe P Roux
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

2.  Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo.

Authors:  Shehab A Ismail; Yong-Xiang Chen; Alexandra Rusinova; Anchal Chandra; Martin Bierbaum; Lothar Gremer; Gemma Triola; Herbert Waldmann; Philippe I H Bastiaens; Alfred Wittinghofer
Journal:  Nat Chem Biol       Date:  2011-10-16       Impact factor: 15.040

3.  Rheb Inhibits Protein Synthesis by Activating the PERK-eIF2α Signaling Cascade.

Authors:  Richa Tyagi; Neelam Shahani; Lindsay Gorgen; Max Ferretti; William Pryor; Po Yu Chen; Supriya Swarnkar; Paul F Worley; Katrin Karbstein; Solomon H Snyder; Srinivasa Subramaniam
Journal:  Cell Rep       Date:  2015-02-07       Impact factor: 9.423

Review 4.  Integration of signals generated by nutrients, hormones, and exercise in skeletal muscle.

Authors:  Scot R Kimball
Journal:  Am J Clin Nutr       Date:  2013-11-27       Impact factor: 7.045

5.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

6.  Evolution of the Ras-like small GTPases and their regulators.

Authors:  Teunis J P van Dam; Johannes L Bos; Berend Snel
Journal:  Small GTPases       Date:  2011-01

7.  The Rheb switch 2 segment is critical for signaling to target of rapamycin complex 1.

Authors:  Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Susann Busch; Joseph Avruch
Journal:  J Biol Chem       Date:  2007-04-30       Impact factor: 5.157

8.  Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.

Authors:  Tatsuhiro Sato; Akio Nakashima; Lea Guo; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

Review 9.  Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.

Authors:  Ken Inoki; Kun-Liang Guan
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

10.  Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.

Authors:  Nancy Lee; Chelsey L Woodrum; Alison M Nobil; Aubrey E Rauktys; Michael P Messina; Sandra L Dabora
Journal:  BMC Pharmacol       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.